Brian Goff

Insider Reports History

Entity
Individual
Location
C/O Alexion Pharmaceuticals, Inc, 100 College Street, New Haven, CT
Signature
/s/ William Cook, as Attorney in Fact for Brian Goff
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Goff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AGIOS PHARMACEUTICALS, INC. Chief Executive Officer, Director Performance share units 76.6K $3.4M $44.39 Jun 5, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Chief Executive Officer, Director Common stock 78.8K $3.37M $42.75 Aug 8, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Chief Executive Officer, Director Restricted stock units 22.7K $995K $43.85 Aug 8, 2024 Direct
Intellia Therapeutics, Inc. Director Common Stock 15.4K $508K $32.99 Jun 13, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Chief Executive Officer, Director Stock options (right to buy) 196K Mar 1, 2024 Direct
Intellia Therapeutics, Inc. Director Stock Option (right to buy) 22.3K Jun 13, 2024 Direct
ALEXION PHARMACEUTICALS, INC. EVP & Chief Commercial Officer Common Stock, par value $.0001 per share 0 $177.00 Jul 21, 2021 Direct
ALEXION PHARMACEUTICALS, INC. EVP & Chief Commercial Officer Option to Purchase Common Stock 0 $155.01 Jul 21, 2021 Direct

Insider Reports Filed by Brian Goff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AGIO AGIOS PHARMACEUTICALS, INC. Aug 8, 2024 3 -$474K 4 Aug 12, 2024 Chief Executive Officer, Director
NTLA Intellia Therapeutics, Inc. Jun 13, 2024 0 $0 3 Jun 17, 2024 Director
NTLA Intellia Therapeutics, Inc. Jun 13, 2024 2 $0 4 Jun 17, 2024 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 5, 2024 3 -$592K 4 Jun 7, 2024 Chief Executive Officer, Director
AGIO AGIOS PHARMACEUTICALS, INC. Mar 1, 2024 5 -$135K 4 Mar 5, 2024 Chief Executive Officer, Director
AGIO AGIOS PHARMACEUTICALS, INC. Jan 20, 2024 3 -$165K 4 Jan 24, 2024 Chief Executive Officer, Director
AGIO AGIOS PHARMACEUTICALS, INC. Jan 5, 2024 3 -$277K 4 Jan 9, 2024 Chief Executive Officer, Director
AGIO AGIOS PHARMACEUTICALS, INC. Aug 8, 2023 3 -$259K 4 Aug 10, 2023 Chief Executive Officer, Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 28, 2023 3 -$325K 4 Jun 30, 2023 Chief Executive Officer, Director
AGIO AGIOS PHARMACEUTICALS, INC. Mar 1, 2023 2 $0 4 Mar 3, 2023 Chief Executive Officer, Director
AGIO AGIOS PHARMACEUTICALS, INC. Aug 8, 2022 0 $0 3/A Aug 9, 2022 Chief Executive Officer, Director
AGIO AGIOS PHARMACEUTICALS, INC. Aug 8, 2022 2 $0 4 Aug 9, 2022 Chief Executive Officer, Director
ALXN ALEXION PHARMACEUTICALS, INC. Jul 21, 2021 2 -$2.18M 4 Jul 23, 2021 EVP & Chief Commercial Officer
ALXN ALEXION PHARMACEUTICALS, INC. Jul 14, 2021 2 $0 4 Jul 16, 2021 EVP & Chief Commercial Officer
ALXN ALEXION PHARMACEUTICALS, INC. Jun 8, 2021 1 -$192K 4 Jun 9, 2021 EVP & Chief Commercial Officer